Skip to main content
Erschienen in: Neuroradiology 12/2011

01.12.2011 | Diagnostic Neuroradiology

Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt–Jakob disease: correlation with clinical course

verfasst von: Jae Hyoung Kim, Byung Se Choi, Cheolkyu Jung, YoungHee Chang, SangYun Kim

Erschienen in: Neuroradiology | Ausgabe 12/2011

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Sporadic Creutzfeldt–Jakob disease (sCJD) is a fatal disease with variable clinical courses. The presence or absence of basal ganglia (BG) involvement has been reported to be associated with clinical course. We investigated the association of clinical course of sCJD with diffusion-weighted imaging (DWI) and MR spectroscopy (MRS) as well as BG involvement at early stage.

Methods

DWI and single voxel proton MRS were performed in 14 patients with sCJD during the initial diagnostic workup. Apparent diffusion coefficient (ADC) and metabolites were measured in medial occipitoparietal cortices where large hyperintense DWI lesions were found in all patients. The presence or absence of BG involvement, ADC, N-acetylaspartate (NAA)/creatine (Cr) ratios, and choline (Cho)/Cr ratios were correlated with disease duration (i.e., the time from the symptom onset to death).

Results

The disease duration ranged from 2 to 31 months (median, 16). Hyperintense DWI lesions were observed bilaterally in both cortices and basal ganglia in eight patients and in cortices alone in six patients. Patients with BG involvement had shorter disease duration (median, 6.8 versus 20.5; p = 0.039) than those without and lower NAA/Cr ratios (median, 1.41 versus 2.03; p = 0.001). ADC and Cho/Cr ratios were not significantly different between the patients with BG involvement and those without. By multiple regression analysis, NAA/Cr ratios had the greatest correlation with the disease duration (p = 0.029).

Conclusion

The disease duration of sCJD was variable. NAA/Cr ratios of the affected brain at the early stage of sCJD can be used as a useful parameter in predicting the clinical course.
Literatur
1.
Zurück zum Zitat Demaerel P, Sciot R, Robberecht W, Dom R, Vandermeulen D, Maes F et al (2003) Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt–Jakob disease. J Neurol 250:222–225PubMedCrossRef Demaerel P, Sciot R, Robberecht W, Dom R, Vandermeulen D, Maes F et al (2003) Accuracy of diffusion-weighted MR imaging in the diagnosis of sporadic Creutzfeldt–Jakob disease. J Neurol 250:222–225PubMedCrossRef
2.
Zurück zum Zitat Mendez OE, Shang J, Jungreis CA, Kaufer DI (2003) Diffusion-weighted MRI in Creutzfeldt–Jakob disease: a better diagnostic marker than CSF protein 14-3-3? J Neuroimaging 13:147–151PubMed Mendez OE, Shang J, Jungreis CA, Kaufer DI (2003) Diffusion-weighted MRI in Creutzfeldt–Jakob disease: a better diagnostic marker than CSF protein 14-3-3? J Neuroimaging 13:147–151PubMed
3.
Zurück zum Zitat Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G (1999) Diffusion-weighted MRI in sporadic Creutzfeldt–Jakob disease. Neurology 52:205–208PubMed Demaerel P, Heiner L, Robberecht W, Sciot R, Wilms G (1999) Diffusion-weighted MRI in sporadic Creutzfeldt–Jakob disease. Neurology 52:205–208PubMed
4.
Zurück zum Zitat Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J (2002) Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt–Jakob disease. Arch Neurol 59:128–134PubMedCrossRef Mittal S, Farmer P, Kalina P, Kingsley PB, Halperin J (2002) Correlation of diffusion-weighted magnetic resonance imaging with neuropathology in Creutzfeldt–Jakob disease. Arch Neurol 59:128–134PubMedCrossRef
5.
Zurück zum Zitat Matsusue E, Kinoshita T, Sugihara S, Fujii S, Ogawa T, Ohama E (2004) White matter lesions in panencephalopathic type of Creutzfeldt–Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 25:910–918PubMed Matsusue E, Kinoshita T, Sugihara S, Fujii S, Ogawa T, Ohama E (2004) White matter lesions in panencephalopathic type of Creutzfeldt–Jakob disease: MR imaging and pathologic correlations. AJNR Am J Neuroradiol 25:910–918PubMed
6.
Zurück zum Zitat Ukisu R, Kushihashi T, Kitanosono T, Fujisawa H, Takenaka H, Ohgiya Y et al (2005) Serial diffusion-weighted MRI of Creutzfeldt–Jakob disease. AJR Am J Roentgenol 184:560–566PubMed Ukisu R, Kushihashi T, Kitanosono T, Fujisawa H, Takenaka H, Ohgiya Y et al (2005) Serial diffusion-weighted MRI of Creutzfeldt–Jakob disease. AJR Am J Roentgenol 184:560–566PubMed
7.
Zurück zum Zitat Bruhn H, Weber T, Thorwirth V, Frahm J (1991) In-vivo monitoring of neuronal loss in Creutzfeldt–Jakob disease by proton magnetic resonance spectroscopy. Lancet 337(8757):1610–1611PubMedCrossRef Bruhn H, Weber T, Thorwirth V, Frahm J (1991) In-vivo monitoring of neuronal loss in Creutzfeldt–Jakob disease by proton magnetic resonance spectroscopy. Lancet 337(8757):1610–1611PubMedCrossRef
8.
Zurück zum Zitat Shyu WC, Lee CC, Hsu YD, Lin JC, Lee JT, Lee WH et al (1996) Panencephalitic Creutzfeldt–Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Neurol Sci 138:157–160PubMedCrossRef Shyu WC, Lee CC, Hsu YD, Lin JC, Lee JT, Lee WH et al (1996) Panencephalitic Creutzfeldt–Jakob disease. Unusual presentation of magnetic resonance imaging and proton magnetic resonance spectroscopy. J Neurol Sci 138:157–160PubMedCrossRef
9.
Zurück zum Zitat Pandya HG, Coley SC, Wilkinson ID, Griffiths PD (2003) Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt–Jakob disease. Clin Radiol 58:148–153PubMedCrossRef Pandya HG, Coley SC, Wilkinson ID, Griffiths PD (2003) Magnetic resonance spectroscopic abnormalities in sporadic and variant Creutzfeldt–Jakob disease. Clin Radiol 58:148–153PubMedCrossRef
10.
Zurück zum Zitat Lim CC, Tan K, Verma KK, Yin H, Venketasubramanian N (2004) Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt–Jakob disease. Magn Reson Imaging 22:625–629PubMedCrossRef Lim CC, Tan K, Verma KK, Yin H, Venketasubramanian N (2004) Combined diffusion-weighted and spectroscopic MR imaging in Creutzfeldt–Jakob disease. Magn Reson Imaging 22:625–629PubMedCrossRef
11.
Zurück zum Zitat Graham GD, Petroff OA, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW (1993) Proton magnetic resonance spectroscopy in Creutzfeldt–Jakob disease. Neurology 43:2065–2068PubMed Graham GD, Petroff OA, Blamire AM, Rajkowska G, Goldman-Rakic P, Prichard JW (1993) Proton magnetic resonance spectroscopy in Creutzfeldt–Jakob disease. Neurology 43:2065–2068PubMed
12.
Zurück zum Zitat Oppenheim C, Zuber M, Galanaud D, Detilleux M, Bolgert F, Mas JL et al (2004) Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt–Jakob disease. J Neurol Neurosurg Psychiatry 75:1066–1069PubMedCrossRef Oppenheim C, Zuber M, Galanaud D, Detilleux M, Bolgert F, Mas JL et al (2004) Spectroscopy and serial diffusion MR findings in hGH-Creutzfeldt–Jakob disease. J Neurol Neurosurg Psychiatry 75:1066–1069PubMedCrossRef
13.
Zurück zum Zitat Masters CL, Richardson EP Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt–Jakob disease). The nature and progression of spongiform change. Brain 101:333–344PubMedCrossRef Masters CL, Richardson EP Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt–Jakob disease). The nature and progression of spongiform change. Brain 101:333–344PubMedCrossRef
14.
Zurück zum Zitat Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L (1998) MRI in sporadic Creutzfeldt–Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 40:65–70PubMedCrossRef Urbach H, Klisch J, Wolf HK, Brechtelsbauer D, Gass S, Solymosi L (1998) MRI in sporadic Creutzfeldt–Jakob disease: correlation with clinical and neuropathological data. Neuroradiology 40:65–70PubMedCrossRef
15.
Zurück zum Zitat Meissner B, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A et al (2004) Sporadic Creutzfeldt–Jakob disease: magnetic resonance imaging and clinical findings. Neurology 63:450–456PubMed Meissner B, Körtner K, Bartl M, Jastrow U, Mollenhauer B, Schröter A et al (2004) Sporadic Creutzfeldt–Jakob disease: magnetic resonance imaging and clinical findings. Neurology 63:450–456PubMed
16.
Zurück zum Zitat Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D et al (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. AJNR Am J Neuroradiol 29:1519–1524PubMedCrossRef Meissner B, Kallenberg K, Sanchez-Juan P, Krasnianski A, Heinemann U, Varges D et al (2008) Isolated cortical signal increase on MR imaging as a frequent lesion pattern in sporadic Creutzfeldt–Jakob disease. AJNR Am J Neuroradiol 29:1519–1524PubMedCrossRef
17.
Zurück zum Zitat Yi SH, Park KC, Yoon SS, Kim EJ, Shin WC (2008) Relationship between clinical course and diffusion-weighted MRI findings in sporadic Creutzfeldt–Jakob disease. Neurol Sci 29:251–255PubMedCrossRef Yi SH, Park KC, Yoon SS, Kim EJ, Shin WC (2008) Relationship between clinical course and diffusion-weighted MRI findings in sporadic Creutzfeldt–Jakob disease. Neurol Sci 29:251–255PubMedCrossRef
18.
Zurück zum Zitat Galanaud D, Haik S, Linguraru MG, Ranjeva JP, Faucheux B, Kaphan E et al (2010) Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases. AJNR Am J Neuroradiol 31:1311–1318PubMedCrossRef Galanaud D, Haik S, Linguraru MG, Ranjeva JP, Faucheux B, Kaphan E et al (2010) Combined diffusion imaging and MR spectroscopy in the diagnosis of human prion diseases. AJNR Am J Neuroradiol 31:1311–1318PubMedCrossRef
19.
Zurück zum Zitat World Health Organization (1998) Global surveillance, diagnosis, and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: World Health Organization: emerging and other communicable disease, surveillance and control; 1998 9–11 February, Geneva World Health Organization (1998) Global surveillance, diagnosis, and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. In: World Health Organization: emerging and other communicable disease, surveillance and control; 1998 9–11 February, Geneva
20.
Zurück zum Zitat Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43PubMedCrossRef Vanhamme L, van den Boogaart A, Van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35–43PubMedCrossRef
21.
Zurück zum Zitat Kim JP, Lentz MR, Westmoreland SV, Greco JB, Ratai EM, Halpern E (2005) Relationships between astrogliosis and 1 H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 26:752–759PubMed Kim JP, Lentz MR, Westmoreland SV, Greco JB, Ratai EM, Halpern E (2005) Relationships between astrogliosis and 1 H MR spectroscopic measures of brain choline/creatine and myo-inositol/creatine in a primate model. AJNR Am J Neuroradiol 26:752–759PubMed
22.
Zurück zum Zitat Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I (2001) Creutzfeldt–Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 25:274–277PubMedCrossRef Matoba M, Tonami H, Miyaji H, Yokota H, Yamamoto I (2001) Creutzfeldt–Jakob disease: serial changes on diffusion-weighted MRI. J Comput Assist Tomogr 25:274–277PubMedCrossRef
23.
Zurück zum Zitat Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J et al (2006) First symptom in sporadic Creutzfeldt–Jakob disease. Neurology 66:286–287PubMedCrossRef Rabinovici GD, Wang PN, Levin J, Cook L, Pravdin M, Davis J et al (2006) First symptom in sporadic Creutzfeldt–Jakob disease. Neurology 66:286–287PubMedCrossRef
Metadaten
Titel
Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt–Jakob disease: correlation with clinical course
verfasst von
Jae Hyoung Kim
Byung Se Choi
Cheolkyu Jung
YoungHee Chang
SangYun Kim
Publikationsdatum
01.12.2011
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 12/2011
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-010-0820-4

Weitere Artikel der Ausgabe 12/2011

Neuroradiology 12/2011 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.